Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

GERON CORPORATION (GERN)

19
Delayed Quote. Delayed Nasdaq - 07/02 04:00:00 pm
4.15 USD   -5.68%
05/11 GERON : The Shuman Law Firm : Investigates Geron Corp.
05/05 GERON : NASDAQ:GERN) Investor Alert: Investigation over Potential Wr..
04/30 GERON : reports 1Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/26/2015 06/29/2015 06/30/2015 07/01/2015 07/02/2015 Date
4.06(c) 4.09(c) 4.28(c) 4.4(c) 4.15(c) Last
5 752 793 4 134 040 5 635 871 7 001 644 2 433 002 Volume
-0.49% +0.74% +4.65% +2.80% -5.68% Change
More quotes
Financials ($)
Sales 2015 27,9 M
EBIT 2015 -8,74 M
Net income 2015 -13,6 M
Debt 2015 -
Yield 2015 -
Sales 2016 1,23 M
EBIT 2016 -19,0 M
Net income 2016 -40,6 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 23,6x
Capi. / Sales 2016 535x
Capitalization 656 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
05/11 GERON : The Shuman Law Firm : Investigates Geron Corp.
05/06 GERON : Harwood Feffer LLP Announces Investigation of Geron Corporation
05/05 GERON : NASDAQ:GERN) Investor Alert: Investigation over Potential Wrongdoing
04/30 GERON : reports 1Q loss
04/30 Geron Corporation Reports First Quarter 2015 Financial Results and Recent Eve..
04/29 GERON : Harwood Feffer LLP : Announces Investigation of Geron Corporation
04/28 GERON : Stock Alert: Schubert Firm Investigates Company's Top Executives
04/27 Geron to Present at the Bank of America Merrill Lynch Healthcare Conference
More news
Sector news : Bio Therapeutic Drugs
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/02 QUINTILES TRANSNATIONAL : and Quest Diagnostics Launch Q2 Solutions
07/01 QUINTILES TRANSNATIONAL : ’ Second Quarter 2015 Earnings Call Scheduled fo..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
07/02 SEEKING ALPHA'S BIOTECH WEEKLY : Celgene-Juno, Gilead's HIV NDA, Happy 4th!
07/01 PREMARKET BIOTECH DIGEST : Geron's Sharp Gain, Bayer Essure AEs, Juno Moves High..
06/29 Geron Is Ripe For A Short Squeeze
06/19 THE BEST PAIRS TRADE IN THE MARKET : Buy Geron And Short Incyte
05/27 Trio Of Small Biotechs With Upcoming 2015 Catalysts And Enormous Long-Term Po..


Comments 
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions